ผศ.พญ.ดนิตา กานต์นฤนิมิต
ABOUT DR. KANNARUNIMIT
Dr.Kannarunimit is a Clinician at King Chulalongkorn Memorial Hospital (KCMH) and Her Royal Highness Princess Maha Chakri Sirindhorn Proton Center (HPSP),Division of Radiation Oncology, Chulalongkorn University in Bangkok. Her research is focused on clinical trials in nasopharyngeal cancer, head neck cancer, and stereotactic radiotherapy in lung cancers and all metastatic sites. She graduated medical degree and board certification in Radiation Oncology from the Faculty of Medicine, Chulalongkorn University in 2010. She completed her research fellowship in Head neck cancer and Stereotactic radiotherapy in Lung cancer -Radiation Oncology from the University of California, San Francisco, and Memorial Sloan Kettering Cancer Center in 2013. Dr.Kannarunimit is a radiation oncologist who specializes in advanced radiation techniques and the treatment of Head and neck, Lung and Metastatic cancers.
ประวัติ
- 2549: แพทยศาสตร์บัณฑิต (เกียรตินิยมอันดับ 1) จุฬาลงกรณ์มหาวิทยาลัย
- 2553: วุฒิบัตรแสดงความรู้ความชำนาญในการประกอบวิชาชีพเวชกรรม สาขารังสีรักษา
- 2006: Doctor of Medicine, Chulalongkorn University
- 2010: Diploma, Thai Board of Radiation Oncology
- 2012: Research Fellowship Department of Radiation Oncology, University of California, San Francisco, USA
- 2013: Research scholarship, , Memorial Sloan Kettering Cancer Center New York, USA
- Present: Instructor, Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn Hospital
Songthong AP, Kannarunimit D, Chakkabat C, Lertbutsayanukul C. A randomized phase II/III study of adverse events between sequential (SEQ) versus simultaneous integrated boost (SIB) intensity modulated radiation therapy (IMRT) in nasopharyngeal carcinoma; preliminary result on acute adverse events. Radiat Oncol. 2015;10:166
Kannarunimit D, Descovich M, Garcia A, Chen J, Weinberg V, Mcguinness C, Pinnaduwage D, Murnane J, Gottschalk AR, Yom SS. Analysis of dose distribution and risk of pneumonitis in stereotactic body radiation therapy for centrally located lung tumors: a comparison of robotic radiosurgery, helical tomotherapy and volumetric modulated arc therapy. Technol Cancer Res Treat. 2015 Feb;14(1):49-60. doi: 10.7785/tcrt.2012.500394. Epub 2014 Nov 11.
Descovich M, McGuinness C, Kannarunimit D, Chen J, Pinnaduwage D, Pouliot J, Kased N, Gottschalk AR, Yom SS.Comparison between target margins derived from 4DCT scans and real-time tumor motion tracking: insights from lung tumor patients treated with robotic radiosurgery. Med Phys. 2015 Mar;42(3):1280-7. doi: 10.1118/1.4907956.
Songthong A, Chakkabat C, Kannarunimit D, Lertbutsayanukul C. Efficacy of intensity-modulated radiotherapy with concurrent carboplatin in nasopharyngeal carcinoma. Radiol Oncol. 2015 Mar 25;49(2):155-62. doi: 10.2478/raon-2014-0044. eCollection 2015.
Anussara Songthong,Chakkapong Chakkabat,Danita Kannarunimit,Chawalit Lertbutsayanukul. Efficacy of Intensity-Modulated Radiotherapy with Concurrent Carboplatin in Nasopharyngeal Carcinoma. Radiology and Oncology. ISSN (Online) 1581-3207, DOI: 10.2478/raon-2014-0044, December 2014.
Kannarunimit D., Descovich M., Garcia A., Chen J. and Yom SS., “Dose analysis and risk of pneumonitis in stereotactic radiotherapy for centrally located lung cancer: Cyberknife, Helical Tomotherapy and Volumetric-modulated arc therapy”, Technol Cancer Restreat. 2013 Nov 6.
Descovich M., Kannarunimit D, and Yom SS. “Cyberknife-based SBRT for lung cancer”, Book chapter in Stereotactic body radiation therapy lung cancer published by Future Medicine 2013
Tam M., Riaz N., Kannarunimit D, Pena A. and Lee N., “Selective neck irradiation in node positive oropharyngeal carcinoma improves xerostomia on prospective self-reported questionnaires”, accepted by JCO 2013
Setton J, Kannarunimit D, Tam M, Suzanne L Wolden S., Rao S., Riaz N. and Lee N. “Long term outcome of definitive radiotherapy of nasopharyngeal carcinoma at a North American Institution”, Abstract ASTRO 2013. On progress of manuscript submittion